SPECIAL SEMINAR - Dr. David ROULOIS UMR INSERM U1236 – MOBIDIC

“Epigenetic and transcriptomic regulation of lymphoid stromal cells in physiological and follicular lymphoma contexts”

Dr. David ROULOIS

UMR INSERM U1236 – MOBIDIC
MicrOenvironment and B-cell: Immunopathology cell DIfferentiation and Cancer
Team Honeycomb : HeterOgeNEitY and COMmitment of B-cell niche

Dr David Roulois obtained his PhD from the University of Nantes for his work on T cell responses in malignant pleural mesothelioma. He then joined the team of Dr. Daniel De Carvalho at the Princess Margaret Cancer Centre (Toronto, Canada), to study the mechanism of “viral mimicry” induction by DNA methyltransferase inhibitors.
Since 2016, he joined the U1236-MOBIDIC unit to study the role of epigenetic mechanisms in the regulation of lymphoid stromal cell polarization and response to inflammation, as well as the deregulation of these mechanisms in the context of follicular lymphoma.